Report cover image

Global Long Non-Coding RNA Sequencing Service Market Growth (Status and Outlook) 2025-2031

Published Aug 13, 2025
Length 115 Pages
SKU # LPI20311373

Description

According to this study, the global Long Non-Coding RNA Sequencing Service market size will reach US$ 1381 million by 2031.

Long Non-Coding RNA (lncRNA) Sequencing Service is a next-generation sequencing (NGS)-based molecular biology service designed to comprehensively detect and analyze long non-coding RNAs—transcripts longer than 200 nucleotides that do not encode proteins but play crucial roles in gene regulation, chromatin remodeling, cell differentiation, and disease pathogenesis. This service involves extracting total RNA, depleting rRNA or mRNA, constructing lncRNA-enriched libraries, performing deep sequencing, and conducting bioinformatics analysis including differential expression profiling, novel lncRNA prediction, target gene analysis, and functional annotation. It is widely used in cancer research, neurological disorders, immune regulation, stem cell biology, and personalized medicine.

United States market for Long Non-Coding RNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Long Non-Coding RNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Long Non-Coding RNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Long Non-Coding RNA Sequencing Service players cover Novogene, Eurofins Scientific, BGI, CD Genomics, Arraystar, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Long Non-Coding RNA Sequencing Service Industry Forecast” looks at past sales and reviews total world Long Non-Coding RNA Sequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Long Non-Coding RNA Sequencing Service sales for 2025 through 2031. With Long Non-Coding RNA Sequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long Non-Coding RNA Sequencing Service industry.

This Insight Report provides a comprehensive analysis of the global Long Non-Coding RNA Sequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long Non-Coding RNA Sequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long Non-Coding RNA Sequencing Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long Non-Coding RNA Sequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long Non-Coding RNA Sequencing Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Long Non-Coding RNA Sequencing Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Strand-Specific Sequencing
Non-Strand-Specific Sequencing

Segmentation by Application:
Oncology Research
Immunology Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novogene
Eurofins Scientific
BGI
CD Genomics
Arraystar
IGE Biotechnology
Mtoz Biolabs
TIANGEN
GentleGen
LC Sciences
Creative Biolabs
Beijing Huaruikang Technology

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

115 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Long Non-Coding RNA Sequencing Service Market Size by Player
4 Long Non-Coding RNA Sequencing Service by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Long Non-Coding RNA Sequencing Service Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.